Ac Immune Stock Piotroski F Score

ACIU Stock  USD 2.73  0.02  0.74%   
This module uses fundamental data of AC Immune to approximate its Piotroski F score. AC Immune F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of AC Immune. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about AC Immune financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out AC Immune Altman Z Score, AC Immune Correlation, AC Immune Valuation, as well as analyze AC Immune Alpha and Beta and AC Immune Hype Analysis.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.
  
At this time, AC Immune's Long Term Debt Total is comparatively stable compared to the past year. Net Debt To EBITDA is likely to gain to 2.88 in 2024, whereas Short Term Debt is likely to drop slightly above 402.5 K in 2024. At this time, AC Immune's Current Ratio is comparatively stable compared to the past year. Tangible Book Value Per Share is likely to gain to 1.57 in 2024, whereas Free Cash Flow Yield is likely to drop (0.18) in 2024.
At this time, it appears that AC Immune's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
Current Return On Assets

Negative

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Decreasing

Focus
Asset Turnover Growth

Decrease

Focus
Current Ratio Change

Increase

Focus
Long Term Debt Over Assets Change

N/A

Focus
Change In Outstending Shares

Decrease

Focus
Change in Gross Margin

No Change

Focus

AC Immune Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to AC Immune is to make sure ACIU is not a subject of accounting manipulations and runs a healthy internal audit department. So, if AC Immune's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if AC Immune's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.07690.081
Notably Down
Slightly volatile
Total Current Liabilities12.8 M13.6 M
Notably Down
Slightly volatile
Non Current Liabilities Total6.9 M8.6 M
Significantly Down
Slightly volatile
Total Assets177.6 M182.8 M
Fairly Down
Slightly volatile
Total Current Assets157.9 M125.2 M
Significantly Up
Slightly volatile

AC Immune F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between AC Immune's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards AC Immune in a much-optimized way.

About AC Immune Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value Per Share

1.7

At this time, AC Immune's Book Value Per Share is comparatively stable compared to the past year.

AC Immune Current Valuation Drivers

We derive many important indicators used in calculating different scores of AC Immune from analyzing AC Immune's financial statements. These drivers represent accounts that assess AC Immune's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of AC Immune's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap581.8M329.2M338.2M157.5M356.0M603.7M
Enterprise Value391.1M170.5M258.9M128.7M281.0M498.1M

AC Immune ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, AC Immune's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to AC Immune's managers, analysts, and investors.
Environmental
Governance
Social

About AC Immune Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AC Immune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AC Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AC Immune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.